Smarter Decisions,
Better Care

UpToDate synthesizes the most recent medical information into evidence-based practical recommendations clinicians trust to make the right point-of-care decisions.

  • Rigorous editorial process: Evidence-based treatment recommendations
  • World-Renowned physician authors: over 5,100 physician authors and editors around the globe
  • Innovative technology: integrates into the workflow; access from EMRs

Choose from the list below to learn more about subscriptions for a:


Subscribers log in here


Related articles

Overview of treatment for pediatric depression

INTRODUCTION

Pediatric depression typically presents in primary care and is undertreated [1]. A nationally representative survey in the United States found that nearly 40 percent of teenagers with major depression or persistent depressive disorder (dysthymia) were not treated [2].

This topic provides an overview of treating pediatric depression. Pharmacotherapy and psychotherapy for juvenile depression, as well as the assessment, diagnosis, and differential diagnosis of depression, are discussed separately.

(See "Pediatric unipolar depression and pharmacotherapy: General principles".)

(See "Pediatric unipolar depression and pharmacotherapy: Choosing a medication".)

(See "Psychosocial treatment for adolescent depression".)

                             

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Oct 2014. | This topic last updated: Nov 12, 2014.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2014 UpToDate, Inc.
References
Top
  1. Olfson M, Blanco C, Wang S, et al. National trends in the mental health care of children, adolescents, and adults by office-based physicians. JAMA Psychiatry 2014; 71:81.
  2. Costello EJ, He JP, Sampson NA, et al. Services for adolescents with psychiatric disorders: 12-month data from the National Comorbidity Survey-Adolescent. Psychiatr Serv 2014; 65:359.
  3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), American Psychiatric Association, Arlington, VA 2013.
  4. Birmaher B, Brent D, AACAP Work Group on Quality Issues, et al. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 2007; 46:1503.
  5. Zuckerbrot RA, Cheung AH, Jensen PS, et al. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): I. Identification, assessment, and initial management. Pediatrics 2007; 120:e1299.
  6. Lewandowski RE, Acri MC, Hoagwood KE, et al. Evidence for the management of adolescent depression. Pediatrics 2013; 132:e996.
  7. Beardslee WR, Salt P, Versage EM, et al. Sustained change in parents receiving preventive interventions for families with depression. Am J Psychiatry 1997; 154:510.
  8. Beardslee WR, Wright EJ, Salt P, et al. Examination of children's responses to two preventive intervention strategies over time. J Am Acad Child Adolesc Psychiatry 1997; 36:196.
  9. Brent DA, Poling K, McKain B, Baugher M. A psychoeducational program for families of affectively ill children and adolescents. J Am Acad Child Adolesc Psychiatry 1993; 32:770.
  10. Fristad, MA, Gavazzi, SM, Centollela, DM, Soldano, KW. Psychoeducation: A promising intervention strategy for families of children and adolescents with mood disorders. Contemp Fam Ther 1996; 18:371.
  11. McClellan JM, Werry JS. Evidence-based treatments in child and adolescent psychiatry: an inventory. J Am Acad Child Adolesc Psychiatry 2003; 42:1388.
  12. Practice guideline for the assessment and treatment of patients with suicidal behaviors. Am J Psychiatry 2003; 160:1.
  13. Rappaport N, Bostic JQ, Prince JB, Jellinek M. Treating pediatric depression in primary care: coping with the patients' blue mood and the FDA's black box. J Pediatr 2006; 148:567.
  14. Stein RE, Zitner LE, Jensen PS. Interventions for adolescent depression in primary care. Pediatrics 2006; 118:669.
  15. Integrated Primary Care. American Academy of Pediatrics (AAP) Children's Mental Health in Primary Care, E-Newsletter. Available at: www.aap.org/mentalhealth. Accessed on February 9, 2009.
  16. Massachusetts Child Psychiatry Access Project. Available at www.mcpap.org. Accessed on February 11, 2009.
  17. Wells KB, Sherbourne C, Schoenbaum M, et al. Impact of disseminating quality improvement programs for depression in managed primary care: a randomized controlled trial. JAMA 2000; 283:212.
  18. Briggs-Gowan MJ, Horwitz SM, Schwab-Stone ME, et al. Mental health in pediatric settings: distribution of disorders and factors related to service use. J Am Acad Child Adolesc Psychiatry 2000; 39:841.
  19. Rushton JL, Clark SJ, Freed GL. Primary care role in the management of childhood depression: a comparison of pediatricians and family physicians. Pediatrics 2000; 105:957.
  20. Richardson LP, Katzenellenbogen R. Childhood and adolescent depression: the role of primary care providers in diagnosis and treatment. Curr Probl Pediatr Adolesc Health Care 2005; 35:6.
  21. Goodfriend M, Bryant T 3rd, Livingood W, Goldhagen J. A model for training pediatricians to expand mental health services in the community practice setting. Clin Pediatr (Phila) 2006; 45:649.
  22. Zuckerbrot RA, Jensen PS. Improving recognition of adolescent depression in primary care. Arch Pediatr Adolesc Med 2006; 160:694.
  23. Kates N. Improving quality of primary care reduces depression and improves quality of life in adolescents. Evid Based Ment Health 2005; 8:76.
  24. Richardson LP, Ludman E, McCauley E, et al. Collaborative care for adolescents with depression in primary care: a randomized clinical trial. JAMA 2014; 312:809.
  25. Cheung AH, Zuckerbrot RA, Jensen PS, et al. Guidelines for Adolescent Depression in Primary Care (GLAD-PC): II. Treatment and ongoing management. Pediatrics 2007; 120:e1313.
  26. Costello EJ. Child psychiatric disorders and their correlates: a primary care pediatric sample. J Am Acad Child Adolesc Psychiatry 1989; 28:851.
  27. Rushton J, Bruckman D, Kelleher K. Primary care referral of children with psychosocial problems. Arch Pediatr Adolesc Med 2002; 156:592.
  28. Williams J, Klinepeter K, Palmes G, et al. Diagnosis and treatment of behavioral health disorders in pediatric practice. Pediatrics 2004; 114:601.
  29. Kelleher KJ, McInerny TK, Gardner WP, et al. Increasing identification of psychosocial problems: 1979-1996. Pediatrics 2000; 105:1313.
  30. Olson AL, Kelleher KJ, Kemper KJ, et al. Primary care pediatricians' roles and perceived responsibilities in the identification and management of depression in children and adolescents. Ambul Pediatr 2001; 1:91.
  31. Briggs-Gowan MJ, Owens PL, Schwab-Stone ME, et al. Persistence of psychiatric disorders in pediatric settings. J Am Acad Child Adolesc Psychiatry 2003; 42:1360.
  32. Skaer, TL, Sclar, DA, Robison, LM. Antidepressant trends among children and adolescents diagnosed with depression: 1990-2001. In: National Institute of Mental Health New Clinical Drug Evaluation Unit Annual Meeting. Phoenix, Arizona 2004.
  33. Asarnow JR, Jaycox LH, Duan N, et al. Effectiveness of a quality improvement intervention for adolescent depression in primary care clinics: a randomized controlled trial. JAMA 2005; 293:311.
  34. Brent DA, Perper JA, Moritz G, et al. Psychiatric risk factors for adolescent suicide: a case-control study. J Am Acad Child Adolesc Psychiatry 1993; 32:521.
  35. Marttunen MJ, Aro HM, Henriksson MM, Lönnqvist JK. Mental disorders in adolescent suicide. DSM-III-R axes I and II diagnoses in suicides among 13- to 19-year-olds in Finland. Arch Gen Psychiatry 1991; 48:834.
  36. Shaffer D, Gould MS, Fisher P, et al. Psychiatric diagnosis in child and adolescent suicide. Arch Gen Psychiatry 1996; 53:339.
  37. Weissman MM, Wolk S, Goldstein RB, et al. Depressed adolescents grown up. JAMA 1999; 281:1707.
  38. Hagman, J. Diagnosis and treatment of depression in adolescence. Adolescent Health Update 2001; :1.
  39. Brent DA, Birmaher B. Clinical practice. Adolescent depression. N Engl J Med 2002; 347:667.
  40. Frank E, Prien RF, Jarrett RB, et al. Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch Gen Psychiatry 1991; 48:851.
  41. Birmaher, B, Brent, D. Pharmacotherapy for depression in children and adolescents. In: The Many Faces of Depression in Children and Adolescents, 1st ed, Shaffer, D, Waslick, BD (Eds), American Psychiatric Association, Washington, DC, 2002. p. 73.
  42. Rush AJ, Kraemer HC, Sackeim HA, et al. Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology 2006; 31:1841.
  43. National Institute for Health and Clinical Excellence. Depression in children and young people. Clinical guideline 28. NICE, London 2005. Available at: www.nice.org.uk/pdf/CG028NICEguideline.pdf. Accessed on August 14, 2007.
  44. Royal Australian College of General Practitioners. Clinical guidance in the use of antidepressant medications in children and adolescents. Available at: www.racgp.org.au/guidelines/antidepressants. Accessed on August 14, 2007.
  45. March, J, Wells, K. Combining medication and psychotherapy. In: Pediatric Psychopharmacology: Principles and Practice, Leckman, JF, Martin, A, Scahill, I, Charney, DS (Eds). Oxford University Press, London 2002. p.426.
  46. March JS, Silva S, Petrycki S, et al. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry 2007; 64:1132.
  47. Brent D, Emslie G, Clarke G, et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA 2008; 299:901.
  48. March J, Silva S, Petrycki S, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA 2004; 292:807.
  49. Dubicka B, Elvins R, Roberts C, et al. Combined treatment with cognitive-behavioural therapy in adolescent depression: meta-analysis. Br J Psychiatry 2010; 197:433.
  50. Cox GR, Callahan P, Churchill R, et al. Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents. Cochrane Database Syst Rev 2012; 11:CD008324.
  51. Treatment for Adolescents With Depression Study Team. Treatment for Adolescents With Depression Study (TADS): rationale, design, and methods. J Am Acad Child Adolesc Psychiatry 2003; 42:531.
  52. March JS, Vitiello B. Clinical messages from the Treatment for Adolescents With Depression Study (TADS). Am J Psychiatry 2009; 166:1118.
  53. Kennard BD, Silva SG, Mayes TL, et al. Assessment of safety and long-term outcomes of initial treatment with placebo in TADS. Am J Psychiatry 2009; 166:337.
  54. Kennard B, Silva S, Vitiello B, et al. Remission and residual symptoms after short-term treatment in the Treatment of Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006; 45:1404.
  55. Kratochvil C, Emslie G, Silva S, et al. Acute time to response in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006; 45:1412.
  56. Emslie G, Kratochvil C, Vitiello B, et al. Treatment for Adolescents with Depression Study (TADS): safety results. J Am Acad Child Adolesc Psychiatry 2006; 45:1440.
  57. Vitiello B, Rohde P, Silva S, et al. Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006; 45:1419.
  58. Curry J, Rohde P, Simons A, et al. Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry 2006; 45:1427.
  59. Tao R, Emslie G, Mayes T, et al. Early prediction of acute antidepressant treatment response and remission in pediatric major depressive disorder. J Am Acad Child Adolesc Psychiatry 2009; 48:71.
  60. Merry SN, Hetrick SE, Cox GR, et al. Psychological and educational interventions for preventing depression in children and adolescents. Cochrane Database Syst Rev 2011; :CD003380.
  61. Lima NN, Nascimento VB, Peixoto JA, et al. Electroconvulsive therapy use in adolescents: a systematic review. Ann Gen Psychiatry 2013; 12:17.
  62. Ghaziuddin N, Dumas S, Hodges E. Use of continuation or maintenance electroconvulsive therapy in adolescents with severe treatment-resistant depression. J ECT 2011; 27:168.
  63. McCauley E, Myers K, Mitchell J, et al. Depression in young people: initial presentation and clinical course. J Am Acad Child Adolesc Psychiatry 1993; 32:714.
  64. Curry J, Silva S, Rohde P, et al. Recovery and recurrence following treatment for adolescent major depression. Arch Gen Psychiatry 2011; 68:263.
  65. Birmaher B, Brent DA, Kolko D, et al. Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder. Arch Gen Psychiatry 2000; 57:29.
  66. Wilkinson P, Dubicka B, Kelvin R, et al. Treated depression in adolescents: predictors of outcome at 28 weeks. Br J Psychiatry 2009; 194:334.
  67. Goodyer IM, Herbert J, Secher SM, Pearson J. Short-term outcome of major depression: I. Comorbidity and severity at presentation as predictors of persistent disorder. J Am Acad Child Adolesc Psychiatry 1997; 36:179.
  68. Asarnow JR, Emslie G, Clarke G, et al. Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response. J Am Acad Child Adolesc Psychiatry 2009; 48:330.
  69. Brent DA, Kolko DJ, Birmaher B, et al. Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression. J Am Acad Child Adolesc Psychiatry 1998; 37:906.
  70. Rohde P, Seeley JR, Kaufman NK, et al. Predicting time to recovery among depressed adolescents treated in two psychosocial group interventions. J Consult Clin Psychol 2006; 74:80.
  71. Birmaher, B, Brent, D. Depressive disorders. In: Pediatric Psychopharmacology: Principles and Practice, Martin, Scahill, et al, (Eds). Oxford University Press, Oxford 2003. p.466.
  72. Emslie GJ, Kennard BD, Mayes TL, et al. Fluoxetine versus placebo in preventing relapse of major depression in children and adolescents. Am J Psychiatry 2008; 165:459.
  73. Parikh SV, Segal ZV, Grigoriadis S, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. II. Psychotherapy alone or in combination with antidepressant medication. J Affect Disord 2009; 117 Suppl 1:S15.
  74. Kennard BD, Emslie GJ, Mayes TL, et al. Cognitive-behavioral therapy to prevent relapse in pediatric responders to pharmacotherapy for major depressive disorder. J Am Acad Child Adolesc Psychiatry 2008; 47:1395.
  75. Kennard BD, Emslie GJ, Mayes TL, et al. Sequential Treatment With Fluoxetine and Relapse-Prevention CBT to Improve Outcomes in Pediatric Depression. Am J Psychiatry 2014; 171:1083.